ArticleParasite (Paris, France)2016
Serological study of Neospora caninum infection in dogs in central China.
Article in Parasite (Paris, France), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 19 citations in OpenAlex.
- Seroprevalence ofAnimals : an open access journal from MDPI · 2026Article
- First molecular identification and phylogenetic analysis ofJournal of veterinary research · 2026Article
- Review of neosporosis: Disease insights and control approaches.Open veterinary journal · 2025Review
- Exploring similarities and differences between Toxoplasma gondii and Neospora caninum infections in dogs.Veterinary research communications · 2024Review
- Molecular and serological prevalence rates of Neospora caninum infection in dogs from Jordan.Parasitology research · 2024Article
- Article
- A recent update about seroprevalence of ovine neosporosis in Northern Egypt and its associated risk factors.Scientific reports · 2021Article
- Molecular and Serological Study of Neospora caninum Infection among Dogs and Foxes in Sanandaj, Kurdistan Province, Iran.Archives of Razi Institute · 2020Article
- Seroprevalence and risk factors for Neospora caninum infection in dogs in rural northeastern mainland China.Parasite (Paris, France) · 2019Article
- Seroprevalence ofVeterinary world · 2018Article
- Prevalence of Neospora spp. in donkeys in China.Parasite (Paris, France) · 2018Article
- Seroprevalence and risk factors of Neospora caninum infection among domestic sheep in Henan province, central China.Parasite (Paris, France) · 2018Article
- A novel loop-mediated isothermal amplification-based test for detecting Neospora caninum DNA.Parasites & vectors · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neospora caninum is a protozoan parasite that causes abortion in cattle as well as reproduction problems and neurological disorders in dogs. Dogs are important in the epidemiology of N. caninum because they act as definitive hosts, shedding oocysts in the environment. To investigate the seroprevalence of N. caninum infection in dogs in central China, 1176 serum samples were collected from domestic dogs in Henan province, central China between March 2015 and February 2016 and tested for IgG antibody against N. caninum, using the indirect fluorescent antibody test (IFAT). The overall seroprevalence of N. caninum was nearly 15% (172/1176). No significant difference was observed between this seroprevalence according to sex and breed of dogs (p > 0.05). The infection rate in rural dogs (18%) was higher (p < 0.05) than in urban dogs (11%). The prevalence of N. caninum infection in dogs increased (p < 0.05) with age. The results of the present study indicate the high prevalence of N. caninum antibodies in dogs in Henan province, central China. Sanitary conditions and animal health must be improved to prevent the transmission risk of N. caninum by dogs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.